rs140936491
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1
The NM_001753.5(CAV1):āc.448A>Gā(p.Ile150Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000836 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001753.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAV1 | NM_001753.5 | c.448A>G | p.Ile150Val | missense_variant | Exon 3 of 3 | ENST00000341049.7 | NP_001744.2 | |
CAV1 | NM_001172895.1 | c.355A>G | p.Ile119Val | missense_variant | Exon 3 of 3 | NP_001166366.1 | ||
CAV1 | NM_001172896.2 | c.355A>G | p.Ile119Val | missense_variant | Exon 2 of 2 | NP_001166367.1 | ||
CAV1 | NM_001172897.2 | c.355A>G | p.Ile119Val | missense_variant | Exon 3 of 3 | NP_001166368.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250924Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135586
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461664Hom.: 0 Cov.: 32 AF XY: 0.0000743 AC XY: 54AN XY: 727138
GnomAD4 genome AF: 0.000105 AC: 16AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74506
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.448A>G (p.I150V) alteration is located in exon 3 (coding exon 3) of the CAV1 gene. This alteration results from a A to G substitution at nucleotide position 448, causing the isoleucine (I) at amino acid position 150 to be replaced by a valine (V). The in silico prediction for the p.I150V alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Pulmonary hypertension, primary, 3 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at